{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ09331",
      "entity_text" : "muscarinic receptor",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:3000322",
      "entity_text" : "scopolamine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Such compounds include the N-methyl-D-aspartate (NMDA) receptor ligand GLYX-13 (i.e., rapastinel), the mGlu2/3 antagonist LY341495, the TrkB agonist 7,8-DHF, and the muscarinic receptor antagonist scopolamine.",
  "reading_complete" : "2020-08-08T20:03:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T20:02:00Z",
  "trigger" : "antagonist",
  "evidence" : [ "muscarinic receptor antagonist scopolamine" ],
  "pmc_id" : "6082376",
  "score" : 0
}